The Anzo Pharma Competitive Intelligence Solution provides real-time monitoring and analysis of public and private information for pharmaceutical organizations' competitive intelligence needs. This solution is used by competitive intelligence teams, business development and licensing teams, marketing groups, and knowledge management teams to proactively deliver up-to-date and relevant information from diverse information sources.
Pharma companies deploy the Anzo Pharma CI Solution to quickly answer questions such as:
* How can we anticipate competitors' new product plans and strategic directions?
* How can we automatically screen thousands of companies for early-stage development programs that align with our strategic goals?
* How do patients' and physicians' perceptions of our and competitors' products help us understand market positioning and develop effective sales strategies?
Anzo ties together information from internal databases with information from vendor content (e.g. Thomson Reuters Life Sciences) and public sources (e.g. NIH content) for a unified view of the key companies, compounds, development programs, drugs, deals, and other entities that drive strategic pharma decisions. Anzo integrates external sources of data as varied as journal articles, grant and intellectual property databases, venture capital portfolios, and conference proceedings. Personalized results are delivered to stakeholders throughout the business via customizable dashboards, reports, spreadsheets, alerts, and workflows.